(Q44198041)

English

The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial (English)

1 reference

Europe PubMed Central

30 November 2017

0 references

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hanefeld M

1

1 reference

Europe PubMed Central

30 November 2017

Sachse G

2

1 reference

Europe PubMed Central

30 November 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

30 November 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

30 November 2017

4

1 reference

Europe PubMed Central

30 November 2017

415-423

1 reference

Europe PubMed Central

30 November 2017

6

1 reference

Europe PubMed Central

30 November 2017

Obesity and diabetes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Long-term effects of modest weight loss in type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

The comparison of four weight reduction strategies aimed at overweight patients with diabetes mellitus: four-year follow-up.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic americans

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00237.X

21 January 2018

Identifiers

10.1046/J.1463-1326.2002.00237.X

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44198041&oldid=2108445629"